DK0701991T3 - Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil - Google Patents

Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil

Info

Publication number
DK0701991T3
DK0701991T3 DK95117572T DK95117572T DK0701991T3 DK 0701991 T3 DK0701991 T3 DK 0701991T3 DK 95117572 T DK95117572 T DK 95117572T DK 95117572 T DK95117572 T DK 95117572T DK 0701991 T3 DK0701991 T3 DK 0701991T3
Authority
DK
Denmark
Prior art keywords
lower alkyl
chem
formula
ring
preparation
Prior art date
Application number
DK95117572T
Other languages
English (en)
Inventor
Sachio Mori
Shozo Takechi
Shiro Kida
Takuji Mizui
Teruhisa Ichihashi
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0701991T3 publication Critical patent/DK0701991T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/221,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one naphthalene or hydrogenated naphthalene ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
DK95117572T 1991-10-17 1992-10-15 Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil DK0701991T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29811991 1991-10-17

Publications (1)

Publication Number Publication Date
DK0701991T3 true DK0701991T3 (da) 1999-09-13

Family

ID=17855421

Family Applications (2)

Application Number Title Priority Date Filing Date
DK92921331.2T DK0597107T3 (da) 1991-10-17 1992-10-15 Lignananalog, fremstilling deraf og hypolipidæmisk medikament
DK95117572T DK0701991T3 (da) 1991-10-17 1992-10-15 Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK92921331.2T DK0597107T3 (da) 1991-10-17 1992-10-15 Lignananalog, fremstilling deraf og hypolipidæmisk medikament

Country Status (12)

Country Link
US (4) US5420333A (da)
EP (2) EP0597107B1 (da)
JP (1) JP2839805B2 (da)
KR (1) KR100252428B1 (da)
AT (2) ATE139990T1 (da)
DE (2) DE69211994T2 (da)
DK (2) DK0597107T3 (da)
ES (2) ES2091488T3 (da)
GR (1) GR3020461T3 (da)
HU (1) HU211296A9 (da)
TW (1) TW209215B (da)
WO (1) WO1993008155A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69411243T2 (de) * 1993-04-16 1998-11-19 Shionogi & Co Verfahren zur herstellung eines lignan-derivats
FR2707980B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux cyclohept[b]indoles et cyclooct[b]indoles, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
AU2353095A (en) * 1994-06-22 1996-01-15 Shionogi & Co., Ltd. Process for producing phthalide compound
ID18046A (id) * 1996-08-20 1998-02-19 Takeda Chemical Industries Ltd Senyawa siklik campuran, pembuatan dan penngunaannya.
EP1135119A4 (en) * 1998-11-12 2004-11-03 Alteon Inc GLUCOSE AND LIPID-REDUCING COMPOUNDS
KR100352269B1 (ko) * 1999-10-08 2002-09-12 한국생명공학연구원 저밀도 지질 단백질에 대해 항산화 활성을 갖는 리그난계 화합물
FR2800738B1 (fr) 1999-11-04 2002-02-08 Corning Sa Naphtopyranes ayant un substituant perfluoroalkyle en position 5, preparation et compositions et matrices (co)polymeres les renfermant
US6770024B1 (en) * 2000-03-28 2004-08-03 Stony Brook Surgical Innovations, Inc. Implantable counterpulsation cardiac assist device
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
CN1466465A (zh) * 2000-08-01 2004-01-07 ��Ұ����ҩ��ʽ���� 肥胖或脂肪肝的预防或治疗药物
JPWO2004033411A1 (ja) * 2002-10-08 2006-02-09 塩野義製薬株式会社 エノンエステルの製造法
US7152611B2 (en) * 2002-12-30 2006-12-26 International Tape Partners, Llc Coated multifilament dental devices overcoated with imbedded particulate
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
ES2552657T3 (es) 2010-05-26 2015-12-01 Satiogen Pharmaceuticals, Inc. Inhibidores del reciclado de ácidos biliares y saciógenos para el tratamiento de diabetes, obesidad, y afecciones gastrointestinales inflamatorias
US20130108573A1 (en) 2011-10-28 2013-05-02 Lumena Pharmaceuticals, Inc. Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
AU2012328526B2 (en) 2011-10-28 2017-05-25 Shire Human Genetic Therapies, Inc. Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
AU2014229050A1 (en) 2013-03-15 2015-10-22 Lumena Pharmaceuticals Llc Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease
CA2907230A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
EP3923943B1 (en) 2019-02-12 2024-07-31 Mirum Pharmaceuticals, Inc. Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficiency

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO170760C (no) * 1985-01-10 1992-12-02 Tanabe Seiyaku Co Analogifremgangsmaate for fremstilling av terapeutisk aktive nafthalenderivater
JPS6310746A (ja) * 1986-07-01 1988-01-18 Tanabe Seiyaku Co Ltd ナフタレン誘導体
JPH0372422A (ja) * 1989-05-16 1991-03-27 Tanabe Seiyaku Co Ltd 抗脂血剤

Also Published As

Publication number Publication date
WO1993008155A1 (fr) 1993-04-29
JP2839805B2 (ja) 1998-12-16
EP0701991A1 (en) 1996-03-20
DE69211994T2 (de) 1997-02-20
DE69228262D1 (de) 1999-03-04
ES2129733T3 (es) 1999-06-16
EP0597107A4 (en) 1994-02-03
US5449814A (en) 1995-09-12
EP0597107A1 (en) 1994-05-18
ATE175954T1 (de) 1999-02-15
ES2091488T3 (es) 1996-11-01
EP0701991B1 (en) 1999-01-20
US5420333A (en) 1995-05-30
GR3020461T3 (en) 1996-10-31
DE69211994D1 (de) 1996-08-08
KR930703236A (ko) 1993-11-29
DK0597107T3 (da) 1996-07-29
JPH05310634A (ja) 1993-11-22
HU211296A9 (en) 1995-11-28
US5731455A (en) 1998-03-24
ATE139990T1 (de) 1996-07-15
KR100252428B1 (ko) 2000-04-15
TW209215B (da) 1993-07-11
EP0597107B1 (en) 1996-07-03
US5502216A (en) 1996-03-26

Similar Documents

Publication Publication Date Title
DK0701991T3 (da) Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil
FI905215A0 (fi) Bensimidazolderivat, deras framstaellning och anvaendning.
PL307087A1 (en) Novel heterocyclic compounds for use as pharmaceuticals
ATE103592T1 (de) Carbamoylpyrrolidonderivate, ihre verwendung und herstellung.
NO881253D0 (no) 1,4-disubstituerte piperazinforbindelser og fremgangsmaate for deres fremstilling.
DK0562439T3 (da) Triazolopyridazinforbindelser, deres fremstilling og anvendelse
EP0632031A4 (da)
ES469953A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalquilbenceno
TR24332A (tr) Fungisid olarak etkili akrilik asit tuerevleri
ES2055077T3 (es) Un procedimiento para preparar derivados de amida de acido carboxilico.
ES2043807T3 (es) Compuestos anticancer.
FI882873A0 (fi) Tiofenderivat och foerfarande foer dess framstaellning.
DK0447135T3 (da) Fremgangsmåde til fremstilling af 1,5-benzothiazepinderivater
DK305879A (da) R fremgangsmaade til fremstilling af oxadiazolpyrimidinderivate
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
ES447910A1 (es) Procedimiento para la preparacion de derivados de acido car-bamico que contienen nitrogeno.
FI882874A0 (fi) Tiofenderivat och foerfarande foer dess framstaellning.
ES2024332A6 (es) Procedimiento para la obtencion de nuevas sulfonamidas.
JPS5653654A (en) Preparation of novel aniline derivative
ATE15659T1 (de) Synthese von indolinen.
DK0555481T3 (da) Tri(C1-C6-alkoxy)benzenderivat.
JPS56100785A (en) 1-azaerythrinan derivative